How late is too late? Timeliness to scheduled visits as an antiretroviral therapy adherence measure in Nairobi, Kenya and Lusaka, Zambia

References

• Attaran , A. 2007 . Adherence to HAART: Africans take medicines more faithfully than North Americans . PLoS Medicine , 4 ( 2 ) : e83
   PubMed Web of Science ®Google Scholar
• Bangsberg , D.R. 2008 . Preventing HIV antiretroviral resistance through better monitoring of treatment adherence . Journal of Infectious Diseases , 197 ( Suppl. 3 ) : S272 – S278 .
   PubMed Web of Science ®Google Scholar
• Berg , K.M. and Arnsten , J.H. 2006 . Practical and conceptual challenges in measuring antiretroviral adherence . Journal of Acquired Immune Deficiency Syndromes , 43 ( Suppl. 1 ) : S79 – S87 .
   PubMed Web of Science ®Google Scholar
• Berg , M.B. , Safren , S.A. , Mimiaga , M.J. , Grasso , C. , Boswell , S. and Mayer , K.H. 2005 . Nonadherence to medical appointments is associated with increased plasma HIV RNA and decreased CD4 cell counts in a community-based HIV primary care clinic . AIDS Care , 17 ( 7 ) : 902 – 907 .
   PubMed Web of Science ®Google Scholar
• Bisson , G.P. , Gross , R. , Bellamy , S. , Chittams , J. , Hislop , M. , Regensberg L. , Nachega , J. 2008 . Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy . PLoS Medicine , 5 5 , e109 .
   PubMed Web of Science ®Google Scholar
• Bisson , G.P. , Rowh , A. , Weinstein , R. , Gaolathe , T. , Frank , I. and Gross , R. 2008 . Antiretroviral failure despite high levels of adherence: Discordant adherence-response relationship in Botswana . Journal of Acquired Immune Deficiency Syndromes , 49 ( 1 ) : 107 – 110 .
   PubMed Web of Science ®Google Scholar
• Carlucci , J.G. , Kamanga , A. , Sheneberger , R. , Shepherd , B.E. , Jenkins , C.A. , Spurrier , J. and Vermund , S.H. 2008 . Predictors of adherence to antiretroviral therapy in rural Zambia . Journal of Acquired Immune Deficiency Syndromes , 47 ( 5 ) : 615 – 622 .
   PubMed Web of Science ®Google Scholar
• Colebunders , R. , Moses , K.R. , Laurence , J. , Shihab , H.M. , Semitala , F. , Lutwama , F. and Mayanja-Kizza , H. 2006 . A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries . Lancet Infectious Diseases , 6 ( 1 ) : 53 – 59 .
   PubMed Web of Science ®Google Scholar
• Gill , C.J. , Hamer , D.H. , Simon , J.L. , Thea , D.M. and Sabin , L.L. 2005 . No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa . AIDS , 19 ( 12 ) : 1243 – 1249 .
   PubMed Web of Science ®Google Scholar
• Jahn , A. , Floyd , S. , Crampin , A.C. , Mwaungulu , F. , Mvula , H. , Munthali , F. and Glynn , J.R. 2008 . Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi . Lancet , 371 ( 9624 ) : 1603 – 1611 .
   PubMed Web of Science ®Google Scholar
• Kouanfack , C. , Laurent , C. , Peytavin , G. , Ciaffi , L. , Ngolle , M. , Nkene , Y.M. and Koulla-Shiro , S. 2008 . Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in Cameroon . Journal of Acquired Immune Deficiency Syndromes , 48 ( 2 ) : 216 – 219 .
   PubMed Web of Science ®Google Scholar
• Krebs , D.W. , Chi , B.H. , Mulenga , Y. , Morris , M. , Cantrell , R.A. , Mulenga , L. and Stringer , J.S.A. 2008 . Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia . AIDS Care , 20 ( 3 ) : 311 – 317 .
   PubMed Web of Science ®Google Scholar
• Laurent , C. , Diakhate , N. , Gueye , N.F. , Toure , M.A. , Sow , P.S. , Faye , M.A. and Delaporte , E. 2002 . The Senegalese government's highly active antiretroviral therapy initiative: An 18-month follow-up study . AIDS , 16 ( 10 ) : 1363 – 1370 .
   PubMed Web of Science ®Google Scholar
• Liechty , C.A. and Bangsberg , D.R. 2003 . Doubts about DOT: Antiretroviral therapy for resource-poor countries . AIDS , 17 ( 9 ) : 1383 – 1387 .
   PubMed Web of Science ®Google Scholar
• Lucas , G.M. , Chaisson , R.E. and Moore , R.D. 1999 . Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions . Annals of Internal Medicine , 131 ( 2 ) : 81 – 87 .
   PubMed Web of Science ®Google Scholar
• Mannheimer , S. , Friedland , G. , Matts , J. , Child , C. and Chesney , M. 2002 . The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials . Clinical Infection Diseases , 34 ( 8 ) : 1115 – 1121 .
   PubMed Web of Science ®Google Scholar
• Mannheimer , S.B. , Matts , J. , Telzak , E. , Chesney , M. , Child , C. , Wu , A.W. and Terry Beirn Community Programs for Clinical Research on , AIDS. 2005 . Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence . AIDS Care , 17 ( 1 ) : 10 – 22 .
   PubMed Web of Science ®Google Scholar
• Mannheimer , S.B. , Mukherjee , R. , Hirschhorn , L.R. , Dougherty , J. , Celano , S.A. , Ciccarone , D. and Finkelstein , R. 2006 . The CASE adherence index: A novel method for measuring adherence to antiretroviral therapy . AIDS Care , 18 ( 7 ) : 853 – 861 .
   PubMed Web of Science ®Google Scholar
• Mills , E.J. , Nachega , J.B. , Bangsberg , D.R. , Singh , S. , Rachlis , B. , Wu , P. and Cooper , C. 2006 . Adherence to HAART: A systematic review of developed and developing nation patient-reported barriers and facilitators . PloS Medicine , 3 ( 11 ) : e438
   PubMed Web of Science ®Google Scholar
• Mills , E.J. , Nachega , J.B. , Buchan , I. , Orbinski , J. , Attaran , A. , Singh , S. and Bangsberg , D.R. 2006 . Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis . JAMA , 296 ( 6 ) : 679 – 690 .
   PubMed Web of Science ®Google Scholar
• Muyingo , S.K. , Walker , A.S. , Reid , A. , Munderi , P. , Gibb , D.M. , Ssali , F. , the DART Trial Team 2008 . Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe . Journal of Acquired Immune Deficiency Syndromes , 48 4 , 468 475 .
   PubMed Web of Science ®Google Scholar
• Nieuwkerk , P.T. and Oort , F.J. 2005 . Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: A meta-analysis . Journal of Acquired Immune Deficiency Syndromes , 38 ( 4 ) : 445 – 448 .
   PubMed Web of Science ®Google Scholar
• Orrell , C. 2005 . Antiretroviral adherence in a resource-poor setting . Current HIV/AIDS Reports , 2 ( 4 ) : 171 – 176 .
   PubMedGoogle Scholar
• Orrell , C. , Bangsberg , D.R. , Badri , M. and Wood , R. 2003 . Adherence is not a barrier to successful antiretroviral therapy in South Africa . AIDS , 17 ( 9 ) : 1369 – 1375 .
   PubMed Web of Science ®Google Scholar
• Oyugi , J.H. , Byakika-Tusiime , J. , Charlebois , E.D. , Kityo , C. , Mugerwa , R. , Mugyenyi , P. and Bangsberg , D.R. 2004 . Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting . Journal of Acquired Immune Deficiency Syndromes , 36 ( 5 ) : 1100 – 1102 .
   PubMed Web of Science ®Google Scholar
• Park , W.B. , Kim , J.Y. , Kim , S.H. , Kim , H.B. , Kim , N.J. , Oh , M.D. and Choe , K.W. 2008 . Self-reported reasons among HIV-infected patients for missing clinic appointments . International Journal of STD and AIDS , 19 ( 2 ) : 125 – 126 .
   PubMed Web of Science ®Google Scholar
• Rastegar , D.A. , Fingerhood , M.I. and Jasinski , D.R. 2003 . Highly active antiretroviral therapy outcomes in a primary care clinic . AIDS Care , 15 ( 2 ) : 231 – 237 .
   PubMed Web of Science ®Google Scholar
• Sethi , A.K. 2004 . Adherence and HIV drug resistance . HIV Clinical Trials , 5 ( 2 ) : 112 – 115 .
   PubMed Web of Science ®Google Scholar
• Sethi , A.K. , Celentano , D.D. , Gange , S.J. , Moore , R.D. and Gallant , J.E. 2003 . Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance . Clinical Infections Disease , 37 ( 8 ) : 1112 – 1118 .
   PubMed Web of Science ®Google Scholar
• Stringer , J.S. , Zulu , I. , Levy , J. , Stringer , E.M. , Mwango , A. , Chi , B.H. and Sinkala , M. 2006 . Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: Feasibility and early outcomes . JAMA , 296 ( 7 ) : 782 – 793 .
   PubMed Web of Science ®Google Scholar
• Stringer , J.S.A. , McConnell , M.S. , Kiarie , J. , Bolu , O. , Anekthananon , T. , Jariyasethpong , T. and Weidle , P.J. 2010 . Effectiveness of non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in women previously exposed to a single intrapartum dose of nevirapine: A multi-country, prospective cohort study . Plos Medicine , 7 ( 2 ) : e1000233
   PubMed Web of Science ®Google Scholar
• Wainberg , M.A. and Friedland , G. 1998 . Public health implications of antiretroviral therapy and HIV drug resistance . JAMA , 279 ( 24 ) : 1977 – 1983 .
   PubMed Web of Science ®Google Scholar
• Weidle , P.J. , Wamai , N. , Solberg , P. , Liechty , C. , Sendagala , S. , Were , W. and Bunnell , R. 2006 . Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda . Lancet , 368 ( 9547 ) : 1587 – 1594 .
   PubMed Web of Science ®Google Scholar